GlassScriptPhysician profile
Sarah E Miller
NPI 1669792164
$1,151.45
in general payments reported to CMS, 2019-2025
14 companies · $238 in 2025
The $238 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $137 · 2022: $216 · 2023: $259 · 2024: $302 · 2025: $238.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $798.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $798.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novocure INC. | $269.08 | 2021-2022 | |
| Abbott Laboratories | $202.09 | 2022-2025 | Infinity |
| Gilead Sciences, INC. | $192.75 | 2023-2025 | |
| Myriad Genetic Laboratories, INC. | $136.59 | 2024-2025 | Myrisk |
| Chiesi USA, INC. | $112.32 | 2023 | Cleviprex |
| Hologic Sales and Service, LLC | $48.04 | 2025 | Trident Specimen Radiography System, Magseed, Magtrace |
| Avanos Medical | $32.11 | 2025 | On-Q Pump and Accessories |
| Ani Pharmaceuticals, INC. | $30.46 | 2023 | Purified Cortrophin Gel |
| Actelion Pharmaceuticals US, INC. | $24.55 | 2024 | Uptravi, Opsumit |
| Eisai INC. | $22.77 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $22.33 | 2025 | Exparel |
| Axogen | $21.35 | 2025 | |
| Aesculap, INC. | $20.93 | 2022 | |
| Ge Healthcare | $16.08 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.